UK 05:40 Thursday, 1 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Advanced Oncotherapy (AVO) is one of the most talked-about shares on the net at the mo. And it’s not just the army of private bloggers who are desperately trying to talk up the share by making fortune teller predictions.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments
TheMadStork
Why did it take so long for the price to shift from 8.25? Same reason; large investors who subscribed to the placing taking profits. The same thing will eventually happen – buying pressure will clear the sellers. Onwards and upwards.
David Russell
Don’t own any of these Malc but I wish the company and shareholders the best of luck and I hope it comes good for everyone but believe half you read and all you see. :)
Marvin
I’m trying to see the negatives but I can’t.
DUCK AND DIVE
So you think the holders of the 262,500,000 new placing shares are in for the long haul like you, Malcolm?
Sadly, that’s not how AIM works. They paid 8p two weeks ago and started dumping at 10p. Most of them probably don’t know or care what AVO do. And not a single solitary individual or institution has bought enough shares to warrant a TR-1 declaration.
As for the directors not being allowed to take part in the placing, shareholders should be asking the Nomad whether he tried to obtain a derogation from Rule 21 (Restriction on deals) from AIM Regulation.
http://burges-salmon.com/Practices/corporate/equity_capital_markets/Publications/AIM_Update_Directors_participation_in_fundraisings_and_share_buybacks.pdf
turbograndad
Have been looking at this one also, yes the story is a good one, but I think investors by and large for this kind of stock more pragmatic, and I think the story is still unfolding, and commercial is the key word.
No doubt it will be commercial hopefully, but that is longer term, maybe at this stage one for the institutions, but small PI,s want to make dosh in the shorter term.
Percieved bargains today at 9.65p, to buy, but selling on some good news RNS, perhaps the true sentiment for some not there yet, and we live in uncertain times, IMHO.
J P Spaghetti
“I’m trying to see the negatives but I can’t.”
Hello again Marvin. That’s because it’s a proton beam – you should be checking out a betatron (or your telly if it’s an old vacuum tube jobbie). Boom-boom!
Marvin
No-one likes a smart-arse Spag
wildrides
Marv ………… true ………..but it was funny ;-)